Oxygenta Pharmaceutical Limited (OXYGENTAPH) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE102E01018
Key metrics
- Market Cap
- ₹214 Cr
- P/E Ratio
- —
- EPS
- -3.67
- Book Value
- -11.54
- P/B Ratio
- —
- ROE
- 41.16%
- ROCE
- -25.4%
- Debt / Equity
- -2.57
- Net Margin
- -15.55%
- Revenue Growth
- 3.37%
- Profit Growth
- -70.63%
- Dividend Yield
- —
- 52W High
- ₹78.89
- 52W Low
- ₹43.00
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Oxygenta Pharmaceutical Limited
Oxygenta Pharmaceutical Limited manufactures and sells pharmaceutical, medical, and veterinary preparations in India and internationally. It offers active pharmaceuticals ingredients, commercial intermediates, and organic fine chemicals, as well as formulations. The company was formerly known as S.S. Organics Limited and changed its name to Oxygenta Pharmaceutical Limited in February 2022. Oxygenta Pharmaceutical Limited was incorporated in 1990 and is based in Hyderabad, India. Oxygenta Pharmaceutical Limited operates as a subsidiary of Virupaksha Organics Limited.
- Headquarters
- Hyderabad, India
- Employees
- 170
- Promoter Holding
- 81.12%
The full Oxygenta Pharmaceutical Limited analysis
Create a free account to open the complete OXYGENTAPH deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.